Prognosis of Stage IV Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) According to the WHO Classification and the Primary Tumor Location Conference

Carmona-Bayonas, A, Jimenez-Fonseca, P, Vieitez, JM et al. (2015). Prognosis of Stage IV Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) According to the WHO Classification and the Primary Tumor Location . 102(1-2), 93-93.

cited authors

  • Carmona-Bayonas, A; Jimenez-Fonseca, P; Vieitez, JM; Menendez Prieto, MD; Soli, MP; Sanchez, ML; Rodriguez, D; Ruiz, AL; Faez, L; Li, W; Uriol, E; Crespo, G; Castano, A; Garcia-Carbonero, R

authors

date/time interval

  • March 11, 2015 -

publication date

  • January 1, 2015

keywords

  • Endocrinology & Metabolism
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • Science & Technology
  • gep-net
  • grade
  • survival
  • who classification

Location

  • SPAIN, Barcelona

Conference

  • 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease

publisher

  • KARGER

start page

  • 93

end page

  • 93

volume

  • 102

issue

  • 1-2